Pfizer CEO: Vaccine third dose 'likely' needed within 12 months

Pfizer CEO: Vaccine third dose 'likely' needed within 12 months
Pfizer CEO: Vaccine third dose 'likely' needed within 12 months

Hello and welcome to the details of Pfizer CEO: Vaccine third dose 'likely' needed within 12 months and now with the details

Nevin Al Sukari - Sana'a - Pfizer CEO Albert Bourla also said annual vaccinations against the coronavirus may well be required. — AFP pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


WASHINGTON, April 16 ― The head of Pfizer said in an interview aired yesterday that people will “likely” need a third dose of his company's Covid-19 vaccine within a year of being fully vaccinated.

CEO Albert Bourla also said annual vaccinations against the coronavirus may well be required.

“We need to see what would be the sequence, and for how often we need to do that, that remains to be seen,” Bourla told CNBC in an interview recorded on April 1.

“A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual revaccination, but all of that needs to be confirmed,” he said, adding that variants will play a “key role.”

“It is extremely important to suppress the pool of people that can be susceptible to the virus,” he said.

Researchers currently don't know how long vaccines provide protection against the coronavirus.

Pfizer published a study earlier this month that said its jab is more than 91 percent effective at protecting against the coronavirus, and more than 95 percent effective against severe cases of Covid-19 up to six months after the second dose.

But researchers say more data is needed to determine whether protection lasts after six months.

David Kessler, the head of US President Joe Biden's Covid-19 response team, warned a congressional committee on Thursday that Americans should expect to receive booster shots to defend against coronavirus variants.

“We don't know everything at this moment,” he told the House Coronavirus Crisis Subcommittee. “We are studying the durability of the antibody response.

“It seems strong but there is some waning of that and no doubt the variants challenge,” he said.

“I think for planning purposes, planning purposes only, I think we should expect that we may have to boost.”

The Pfizer vaccine, developed in partnership with German firm BioNTech, currently plays a leading role in American and European vaccination campaigns.

The pharmaceutical giant announced in February that it was testing a third dose of its vaccine to better combat the emerging variants. ― AFP

These were the details of the news Pfizer CEO: Vaccine third dose 'likely' needed within 12 months for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Long-haul carrier Emirates to ship aid for free into India
NEXT India's lauds Gulf assistance in fighting COVID-19